PMC:7377212 / 4221-4456 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T7","span":{"begin":123,"end":127},"obj":"Body_part"}],"attributes":[{"id":"A7","pred":"fma_id","subj":"T7","obj":"http://purl.org/sig/ont/fma/fma7195"}],"text":" 16 (48%) had exposure to inhaled or systemic corticosteroids, 10 (30%) had diabetes and nine (27%) had underlying chronic lung disease; COPD (n=5), asthma (n=3), bullous emphysema (n=1), pulmonary fibrosis (n=1) and post-radiotherapy "}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T8","span":{"begin":123,"end":127},"obj":"Body_part"}],"attributes":[{"id":"A8","pred":"uberon_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":" 16 (48%) had exposure to inhaled or systemic corticosteroids, 10 (30%) had diabetes and nine (27%) had underlying chronic lung disease; COPD (n=5), asthma (n=3), bullous emphysema (n=1), pulmonary fibrosis (n=1) and post-radiotherapy "}

{"project":"LitCovid-PubTator","denotations":[{"id":"155","span":{"begin":76,"end":84},"obj":"Disease"},{"id":"156","span":{"begin":123,"end":135},"obj":"Disease"},{"id":"157","span":{"begin":137,"end":141},"obj":"Disease"},{"id":"158","span":{"begin":149,"end":155},"obj":"Disease"},{"id":"159","span":{"begin":171,"end":180},"obj":"Disease"},{"id":"160","span":{"begin":188,"end":206},"obj":"Disease"}],"attributes":[{"id":"A155","pred":"tao:has_database_id","subj":"155","obj":"MESH:D003920"},{"id":"A156","pred":"tao:has_database_id","subj":"156","obj":"MESH:D008171"},{"id":"A157","pred":"tao:has_database_id","subj":"157","obj":"MESH:D029424"},{"id":"A158","pred":"tao:has_database_id","subj":"158","obj":"MESH:D001249"},{"id":"A159","pred":"tao:has_database_id","subj":"159","obj":"MESH:D004646"},{"id":"A160","pred":"tao:has_database_id","subj":"160","obj":"MESH:D011658"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" 16 (48%) had exposure to inhaled or systemic corticosteroids, 10 (30%) had diabetes and nine (27%) had underlying chronic lung disease; COPD (n=5), asthma (n=3), bullous emphysema (n=1), pulmonary fibrosis (n=1) and post-radiotherapy "}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T73","span":{"begin":76,"end":84},"obj":"Disease"},{"id":"T74","span":{"begin":123,"end":135},"obj":"Disease"},{"id":"T75","span":{"begin":137,"end":141},"obj":"Disease"},{"id":"T76","span":{"begin":149,"end":155},"obj":"Disease"},{"id":"T77","span":{"begin":171,"end":180},"obj":"Disease"},{"id":"T78","span":{"begin":188,"end":206},"obj":"Disease"}],"attributes":[{"id":"A73","pred":"mondo_id","subj":"T73","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A74","pred":"mondo_id","subj":"T74","obj":"http://purl.obolibrary.org/obo/MONDO_0005275"},{"id":"A75","pred":"mondo_id","subj":"T75","obj":"http://purl.obolibrary.org/obo/MONDO_0005002"},{"id":"A76","pred":"mondo_id","subj":"T76","obj":"http://purl.obolibrary.org/obo/MONDO_0004979"},{"id":"A77","pred":"mondo_id","subj":"T77","obj":"http://purl.obolibrary.org/obo/MONDO_0004849"},{"id":"A78","pred":"mondo_id","subj":"T78","obj":"http://purl.obolibrary.org/obo/MONDO_0002771"}],"text":" 16 (48%) had exposure to inhaled or systemic corticosteroids, 10 (30%) had diabetes and nine (27%) had underlying chronic lung disease; COPD (n=5), asthma (n=3), bullous emphysema (n=1), pulmonary fibrosis (n=1) and post-radiotherapy "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T29","span":{"begin":5,"end":7},"obj":"http://purl.obolibrary.org/obo/CLO_0001382"},{"id":"T30","span":{"begin":95,"end":97},"obj":"http://purl.obolibrary.org/obo/CLO_0050509"},{"id":"T31","span":{"begin":123,"end":127},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T32","span":{"begin":123,"end":127},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"}],"text":" 16 (48%) had exposure to inhaled or systemic corticosteroids, 10 (30%) had diabetes and nine (27%) had underlying chronic lung disease; COPD (n=5), asthma (n=3), bullous emphysema (n=1), pulmonary fibrosis (n=1) and post-radiotherapy "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T5","span":{"begin":46,"end":61},"obj":"Chemical"}],"attributes":[{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"}],"text":" 16 (48%) had exposure to inhaled or systemic corticosteroids, 10 (30%) had diabetes and nine (27%) had underlying chronic lung disease; COPD (n=5), asthma (n=3), bullous emphysema (n=1), pulmonary fibrosis (n=1) and post-radiotherapy "}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T9","span":{"begin":115,"end":135},"obj":"Phenotype"},{"id":"T10","span":{"begin":137,"end":141},"obj":"Phenotype"},{"id":"T11","span":{"begin":149,"end":155},"obj":"Phenotype"},{"id":"T12","span":{"begin":171,"end":180},"obj":"Phenotype"},{"id":"T13","span":{"begin":188,"end":206},"obj":"Phenotype"}],"attributes":[{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0006528"},{"id":"A10","pred":"hp_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/HP_0006510"},{"id":"A11","pred":"hp_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/HP_0002099"},{"id":"A12","pred":"hp_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/HP_0002097"},{"id":"A13","pred":"hp_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/HP_0002206"}],"text":" 16 (48%) had exposure to inhaled or systemic corticosteroids, 10 (30%) had diabetes and nine (27%) had underlying chronic lung disease; COPD (n=5), asthma (n=3), bullous emphysema (n=1), pulmonary fibrosis (n=1) and post-radiotherapy "}